Rochester, NY (PRWEB) March 31, 2014
A new clinical study proves that Gene-Eden-VIR reduces physical and mental fatigue in individuals infected with a latent virus (1). The study was published in the peer reviewed, scientific journal Pharmacology & Pharmacy.
To be more specific, the clinical study showed that Gene-Eden-VIR reduced fatigue in those infected with a latent virus including: “the Human Papillomavirus (HPV), Epstein Barr Virus (EBV), Herpes Simplex Virus (HSV), Human Cytomegalovirus (HCMV), and Hepatitis C Virus (HCV) (1).”
This study is unique in the health industry since there are no drugs approved by the FDA to specifically treat fatigue. Now, however, a clinical study showed that Gene-Eden-VIR, a natural antiviral, reduces fatigue. This is important since fatigue is very common. “Studies have shown that one-third of the general population reports a feeling of fatigue, with 5% reporting a feeling of short-term fatigue (<6 months), and 31% reporting a feeling of long term or chronic fatigue. In the US alone, the feeling of fatigue is responsible for 10 - 15 million visits to the family doctor every year (1).”
Moreover, “Various diseases (e.g., anemia, multiple sclerosis, CFS), psychiatric disorders, and drugs (e.g., antihypertensives, β-adrenergic blockers, lipid-lowering agents) can cause a feeling of fatigue. One of the most important causes of a feeling of fatigue is an infection, specifically, with a latent virus, such as the Epstein-Barr virus (EBV), human herpesvirus 6 (HHV-6), human herpesvirus 7 (HHV-7), herpes simplex virus (HSV), human immunodeficiency virus (HIV), hepatitis viruses, parvovirus B19, and influenza virus (1).” Those with fatigue usually have a sense of tiredness, lack of energy, a feeling of exhaustion, and impaired physical and/or cognitive performance.
Importantly, study participants reported no side effects when using Gene-Eden-VIR, and following treatment, the participants reported a statistically significant decrease in every aspect of fatigue tested in the study (1).
This is the second time that a peer reviewed medical journal published a paper reporting a clinical study on Gene-Eden-VIR’s, patent protected, natural formula. The first paper, entitled “Gene-Eden-VIR Is Antiviral: Results of a Post Marketing Clinical Study” was published in September 2013 and can be found at: http://www.scirp.org/journal/PaperInformation.aspx?PaperID=36101#.UzQEv6iSz90
Mike Evans of polyDNA said “We believe in natural products. There are many untapped opportunities in this field that deserve serious scientific research. We are very happy that we were both successful in developing a natural product, and in proving that it works through a clinical study that followed FDA guidelines. As our mission says, polyDNA aims to develop and sell natural products that are as safe and effective as drugs.”
To view the entire paper on Gene-Eden-VIR and fatigue, visit: http://www.scirp.org/journal/PaperInformation.aspx?PaperID=44234#.UzQC5KiSz90
For more information on Gene-Eden-VIR please visit the product’s official website at: http://www.gene-eden-vir.com.
We invite the media to contact us for interviews at: note (AT) buy-gene-eden.com or phone 585-250-9999.
polyDNA is a biotechnology company that develops dietary supplements using the unique scientific method developed by Dr. Hanan Polansky, which is based on Computer Intuition.
In addition to his unique scientific method, Dr. Polansky published the highly acclaimed scientific discovery, called Microcompetition with Foreign DNA. The discovery explains how foreign DNA fragments, and specifically, DNA of latent viruses, cause most major diseases.
polyDNA developed Gene-Eden-VIR, an antiviral natural remedy that helps the immune system kill latent viruses.